These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34331378)

  • 1. Possible role of the mitochondrial genome in the pathogenesis of autosomal dominant polycystic kidney disease.
    Saravanabavan S; Rangan GK
    Nephrology (Carlton); 2021 Nov; 26(11):920-930. PubMed ID: 34331378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
    Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.
    Hopp K; Kleczko EK; Gitomer BY; Chonchol M; Klawitter J; Christians U; Klawitter J
    Am J Physiol Renal Physiol; 2022 Mar; 322(3):F258-F267. PubMed ID: 35037466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilia and polycystic kidney disease.
    Ma M
    Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
    Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
    BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.
    Saigusa T; Bell PD
    Physiology (Bethesda); 2015 May; 30(3):195-207. PubMed ID: 25933820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Mechanisms of ADPKD.
    Kim DY; Park JH
    Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of a novel mutation in a Tunisian child with polycystic kidney disease.
    Abdelwahed M; Hilbert P; Ahmed A; Dey M; Kamoun H; Ammar-Keskes L; Belguith N
    IUBMB Life; 2020 Aug; 72(8):1799-1806. PubMed ID: 32472977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polycystin-centric view of cyst formation and disease: the polycystins revisited.
    Ong AC; Harris PC
    Kidney Int; 2015 Oct; 88(4):699-710. PubMed ID: 26200945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
    Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
    BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele.
    Reiterová J; Štekrová J; Merta M; Kotlas J; Elišáková V; Lněnička P; Korabečná M; Kohoutová M; Tesař V
    BMC Nephrol; 2013 Mar; 14():59. PubMed ID: 23496908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
    Hoefele J; Mayer K; Scholz M; Klein HG
    Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cGAS Activation Accelerates the Progression of Autosomal Dominant Polycystic Kidney Disease.
    Yoo M; Haydak JC; Azeloglu EU; Lee K; Gusella GL
    J Am Soc Nephrol; 2024 Apr; 35(4):466-482. PubMed ID: 38247039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional in vitro models answer the right questions in ADPKD cystogenesis.
    Dixon EE; Woodward OM
    Am J Physiol Renal Physiol; 2018 Aug; 315(2):F332-F335. PubMed ID: 29693448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.
    Abdelwahed M; Hilbert P; Ahmed A; Mahfoudh H; Bouomrani S; Dey M; Hachicha J; Kamoun H; Keskes-Ammar L; Belguith N
    Gene; 2018 Sep; 671():28-35. PubMed ID: 29860066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
    Carrera P; Calzavara S; Magistroni R; den Dunnen JT; Rigo F; Stenirri S; Testa F; Messa P; Cerutti R; Scolari F; Izzi C; Edefonti A; Negrisolo S; Benetti E; Alibrandi MT; Manunta P; Boletta A; Ferrari M
    Sci Rep; 2016 Aug; 6():30850. PubMed ID: 27499327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
    Cai Y; Tang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives of Gene Therapies in Autosomal Dominant Polycystic Kidney Disease.
    Xu Y; Li A; Wu G; Liang C
    Curr Gene Ther; 2017; 17(1):43-49. PubMed ID: 28494735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
    Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
    Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease.
    Kocyigit I; Ozturk F; Eroglu E; Karaca Z; Kaynar AS; Cetin M; Tokgoz B; Sipahioglu MH; Bayramov R; Sen A; Oymak O; Ecder T; Axelsson J
    Clin Exp Nephrol; 2019 Sep; 23(9):1130-1140. PubMed ID: 31134465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.